Difference Between Fibrin and Fibrinogen
Fibrinogen is the soluble precursor protein circulating in blood plasma, while fibrin is the insoluble polymer formed when thrombin cleaves fibrinopeptides from fibrinogen, creating the structural scaffold of blood clots 1.
Molecular Structure and Composition
Fibrinogen
- Soluble glycoprotein synthesized primarily in the liver with normal plasma concentration of 1.5-3.5 g/L, making it the most abundant blood coagulation factor 2
- Consists of two identical subunits, each formed by three non-identical polypeptide chains: Aα, Bβ, and γ chains 1
- The "A" and "B" designations in the Aα and Bβ chains refer to fibrinopeptide A (FpA, residues 1-16) and fibrinopeptide B (FpB, residues 1-14), which remain attached in the fibrinogen molecule 1
- Measures 45 nm in length with globular domains at each end (D regions) and in the middle (E region) connected by α-helical coiled-coil rods 3
Fibrin
- Insoluble polymer formed after thrombin enzymatically cleaves fibrinopeptides from fibrinogen 1
- After FpA and FpB removal, the resulting chains are designated as α chain (no longer Aα) and β chain (no longer Bβ), while the γ chain remains unchanged 1
- Forms a three-dimensional network through specific "knob-hole" interactions between molecules 4
The Conversion Process
The transformation from fibrinogen to fibrin occurs through a precisely controlled enzymatic cascade:
Thrombin cleavage: Thrombin removes fibrinopeptide A (residues 1-16) from the Aα chains and fibrinopeptide B (residues 1-14) from the Bβ chains 1
Polymerization initiation: Removal of fibrinopeptides exposes binding sites ("knobs") in the central E region that interact with constitutively available "holes" at the D regions of adjacent molecules 4, 3
Fibril formation: Half-staggered, double-stranded oligomers elongate into protofibrils, which aggregate laterally to form fibers and branch to create the three-dimensional clot network 4
Cross-linking: Factor XIIIa covalently cross-links fibrin molecules through isopeptide bonds between glutamine and lysine residues, stabilizing the clot against mechanical and proteolytic degradation 4, 3
Functional Differences
Fibrinogen Functions
- Circulates as an inactive precursor awaiting activation
- Binds to activated αIIbβ3 integrin on platelets, mediating platelet aggregation 4
- Soluble fibrinogen inhibits immune cell recruitment, providing a protective anti-inflammatory effect 5
Fibrin Functions
- Provides the structural scaffold for hemostatic clots and pathological thrombi 2
- Protects thrombin from antithrombins by adsorption, maintaining physiologically active thrombin that can activate factors V, VIII, and platelets 5
- Activates monocytes/macrophages and neutrophils via Mac-1 interactions, eliciting a pro-inflammatory response 5
- Creates a viscoelastic polymer with mechanical properties determined by fiber thickness, network density, and pore size 2
- Binds tissue-type plasminogen activator (tPA) and plasminogen, forming a ternary complex that facilitates fibrinolysis 4
Clinical Significance
The distinction between fibrinogen and fibrin has important clinical implications:
- Fibrin clots with high fiber density and increased resistance to fibrinolysis are consistently associated with thrombotic risk 6
- While elevated plasma fibrinogen levels are a known risk factor for thrombosis, the immobilized fibrin matrices exert both direct prothrombotic effects (by protecting thrombin) and indirect effects (through immune system activation) 5
- Paradoxically, high soluble fibrinogen levels may provide some protection due to immune-suppressive functions, contrasting with the prothrombotic nature of deposited fibrin 5
Laboratory Assessment
Fibrinogen determination using the Clauss method remains the gold standard for measuring circulating fibrinogen levels 7. Research assays evaluate fibrin clot properties including permeability, fiber thickness, pore size, and mechanical strength using techniques like rheometry and atomic force microscopy 7.